JE
Insider
James Edgemond
CFO AND TREASURERJames Edgemond (CFO AND TREASURER) filed 34 Form 4 reports in the trailing twelve months (0 purchases, 34 sales), most often in United Therapeutics Corporation (UTHR). The largest single filing was $10.0M of UTHR (20,840 sh across 6 lots, as filed), executed Dec 1 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
34
0 buys · 34 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$208.4M
shares × price, as filed
Last traded
Jun 22
Filed Jun 23
Median ADV $265.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $232.8M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
34 filings
Sector per market data · by filing · past 12 months
Most traded names
UTHRRecent filings
UTHRSALE
United Therapeutics Corporation
View filing →
$5.6M9,476 sh across 16 lots
Exec Mar 30
Filed Mar 31 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $5.4M
10,000 sh across 9 lots
Exec Mar 26
Filed Mar 27 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $5.1M
9,760 sh across 15 lots
Exec Mar 23
Filed Mar 24 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $1.6M
3,157 sh across 7 lots
Exec Dec 15 2025
Filed Dec 16 2025 · 5:30 PM ET